However, MALA patients with unpredictable and combined metformin contraindications presented the borderline significant lower risk of hypoglycemia (OR:0.17, 95% CI: 0.03–1.09, =0.0611 for unpredictable group; OR:0.18, 95% CI:0.03–1.00, =0.0502 for combined group) than those with avoidable contraindications.
← all excerpts
Metformin use despite contraindications in metformin-associated lactic acidosis.
1
—
—